PURPOSE OF REVIEW: This update addressing head and neck sarcoma presents new data published after January 2003. This new information is presented following review of contemporary management principles established before 2003. RECENT FINDINGS: The application of advances in molecular and genetic techniques to characterize individual sarcomas has improved classification schemes and hopefully will lead to individually tailored therapy. Maturation and refinements of large tumor registries are permitting more detailed analysis of larger contemporary series of the rare head and neck sarcomas. Improved long-term survival of patients treated for sarcoma in their childhood has allowed study of the morbidity induced by treatment. Novel treatment strategies are under study to decrease morbidity without diminishing the chance for cure. SUMMARY: Progress in improving the treatment of sarcoma of the head and neck has been slow due to the lack of a large clinical experience with this rare neoplasm. Advances continue and are anticipated to be most striking in the study of genetic mechanisms.
PURPOSE OF REVIEW: This update addressing head and neck sarcoma presents new data published after January 2003. This new information is presented following review of contemporary management principles established before 2003. RECENT FINDINGS: The application of advances in molecular and genetic techniques to characterize individual sarcomas has improved classification schemes and hopefully will lead to individually tailored therapy. Maturation and refinements of large tumor registries are permitting more detailed analysis of larger contemporary series of the rare head and neck sarcomas. Improved long-term survival of patients treated for sarcoma in their childhood has allowed study of the morbidity induced by treatment. Novel treatment strategies are under study to decrease morbidity without diminishing the chance for cure. SUMMARY: Progress in improving the treatment of sarcoma of the head and neck has been slow due to the lack of a large clinical experience with this rare neoplasm. Advances continue and are anticipated to be most striking in the study of genetic mechanisms.
Authors: Mohamedtaki A Tejani; Thomas J Galloway; Miriam Lango; John A Ridge; Margaret von Mehren Journal: Cancers (Basel) Date: 2013-07-15 Impact factor: 6.639
Authors: Johannes Zeller; Jurij Kiefer; David Braig; Oscar Winninger; Daniel Kraus; Salome Hagelstein; Steffen U Eisenhardt Journal: Cancers (Basel) Date: 2022-06-10 Impact factor: 6.575
Authors: Kripa Guram; Maria Nunez; John Einck; Loren K Mell; Ezra Cohen; P Dominick Sanders; Sayuri Miyauchi; Elizabeth Weihe; Razelle Kurzrock; Sarah Boles; Andrew B Sharabi Journal: Front Oncol Date: 2018-10-17 Impact factor: 6.244
Authors: Isabela Alves Pacheco; Ana Paula Negreiros Nunes Alves; Mário Rogério Lima Mota; Paulo César de Almeida; Marcelo Esmeraldo Holanda; Eric Fernandes de Souza; Fabricio Bitu Sousa Journal: Braz J Otorhinolaryngol Date: 2011-06